Literature DB >> 6954491

Possible role of ceramide in defining structure and function of membrane glycolipids.

R Kannagi, E Nudelman, S Hakomori.   

Abstract

A possible role of ceramide in defining the carbohydrate structure of glycolipids and the expression of glycolipid function has been proposed, on the basis of our finding that the ceramide composition of "lacto-series" glycosphingolipid isolated from human erythrocytes shows a remarkable correlation with the terminal carbohydrate structure: (i) The ceramides of three glycosphingolipids with Lex (or x) determinant [Gal beta 1 leads to 4(Fuc alpha 1 leads to 3) GlcNAc] had almost exclusively 16:0 fatty acid; in contrast, the ceramide of its positional isomer H determinant had mainly 20--24:0 fatty acids. (ii) The ceramide of two glycosphingolipids with NeuAc alpha 2 leads to 6GAL structure was predominantly of 16:0 fatty acid, in contrast to that of its positional isomer NeuAc alpha 2 leads to 3Gal residue, in which the ceramide had 20--24:0 fatty acids. These results, together with our previous observation that ceramide composition of mouse lymphoma and myelocytic leukemia MI cells affects their antigenicity, suggest that ceramide structure may define the organization of glycosyltransferase for synthesis of the carbohydrate determinants and may affect the organization and orientation of the carbohydrate chain in membranes, eliciting or suppressing the reactivity to its ligand. Because these glycolipids with Lex and NeuAc alpha 2 leads to 6Gal structures are developmentally regulated and are highly expressed in certain tumors, ceramide composition may affect development, differentiation, and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954491      PMCID: PMC346442          DOI: 10.1073/pnas.79.11.3470

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Surface carbohydrates of hamster fibroblasts. II. Interaction of hamster NIL cell surfaces with Ricinus communis lectin and concanavalin A as revealed by surface galactosyl label.

Authors:  C G Gahmberg; S Hakomori
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  Differentiation of a cell line of myeloid leukemia.

Authors:  Y Ichikawa
Journal:  J Cell Physiol       Date:  1969-12       Impact factor: 6.384

3.  The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellular adhesion.

Authors:  S Roseman
Journal:  Chem Phys Lipids       Date:  1970-10       Impact factor: 3.329

4.  A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose 3.

Authors:  H J Yang; S I Hakomori
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

Review 5.  Immunochemical properties of glycolipids and phospholipids.

Authors:  D M Marcus; G A Schwarting
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

6.  alpha-L-Fucopyranosylceramide, a novel glycolipid accumulated in some of the human colon tumors.

Authors:  K Watanabe; T Matsubara; S Hakomori
Journal:  J Biol Chem       Date:  1976-04-25       Impact factor: 5.157

7.  On neutral fucoglycolipids having long, branched carbohydrate chains: H-active and I-active glycosphingolipids of human erythrocyte membranes.

Authors:  K Watanabe; R A Laine; S I Hakomori
Journal:  Biochemistry       Date:  1975-06-17       Impact factor: 3.162

8.  Changes in sphingosine and fatty acid components of the gangliosides in developing rat and human brain.

Authors:  A Rosenberg; N Stern
Journal:  J Lipid Res       Date:  1966-01       Impact factor: 5.922

9.  Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes.

Authors:  D M Marcus; M Naiki; S K Kundu
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

10.  Gangliosides of human, bovine, and rabbit plasma.

Authors:  R K Yu; R W Ledeen
Journal:  J Lipid Res       Date:  1972-09       Impact factor: 5.922

View more
  27 in total

Review 1.  Immunogenicity of glycolipids.

Authors:  J Portoukalian
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

3.  Dr. Sen-itiroh Hakomori.

Authors:  M Fukuda; Y T Li
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 4.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 5.  Aglycone modulation of glycolipid receptor function.

Authors:  C A Lingwood
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

6.  Rapid Profiling of Bovine and Human Milk Gangliosides by Matrix-Assisted Laser Desorption/Ionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

Authors:  Hyeyoung Lee; Hyun Joo An; Larry A Lerno; J Bruce German; Carlito B Lebrilla
Journal:  Int J Mass Spectrom       Date:  2011-08-15       Impact factor: 1.986

7.  Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl ceramide.

Authors:  T Daino; K Tsuchihashi; M Kashiwagi; Y Yachida; T Akino; S Gasa
Journal:  Glycoconj J       Date:  1999-01       Impact factor: 2.916

Review 8.  A glycosynapse in myelin?

Authors:  Joan M Boggs; Huimin Wang; Wen Gao; Dina N Arvanitis; Yanping Gong; Weixian Min
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

9.  Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.

Authors:  R Ghidoni; S Sonnino; V Chigorno; B Venerando; G Tettamanti
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

10.  Piglet ileal mucus contains protein and glycolipid (galactosylceramide) receptors specific for Escherichia coli K88 fimbriae.

Authors:  L Blomberg; H C Krivan; P S Cohen; P L Conway
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.